Treatment of fibrosis With RAF inhibitors

Lists

Download

Preview

Published Application_Angela Clerk.pdf - Published Version (6MB) | Preview

Preview

Spec as filed - 3 Feb 20 - N415228WO.PDF - Accepted Version (6MB) | Preview

Preview

Drawings as filed - 3 Feb 20 - N415228WO.PDF - Supplemental Material (7MB) | Preview

Preview

Publication notice N415228WO.PDF - Other (46kB) | Preview

Tools

St George's Hospital Medical School (2020) Treatment of fibrosis With RAF inhibitors. WO 2020/161477. doi: WO 2020/161477

Item Type	Patent
URI	https://reading-clone.eprints-hosting.org/id/eprint/95346
Item Type	Patent
Divisions	Life Sciences > School of Biological Sciences > Biomedical Sciences
Download/View statistics	View download statistics for this item

Download Statistics

Downloads

Downloads per month over past year

Funded Project

Funders:	British Heart Foundation	The sponsoring bodies who contributed funding for the creation of this item. Example: NERC Example: The Royal Society of Chemistry A pick list of funders may appear as you type in the funder's name in full or as an acronym. Select a correct match to complete the field or type in a new entry in full. For new entries, the full name is preferred.
Projects:	The role of BRaf in the heart and cardiac effects vemurafenib, dabrafenib and trametinib, recently licensed cancer therapies that target BRaf and MKK1/2 Funded by: British Heart Foundation (PG/13/71/30460 - £262,981) Local Lead (PI): Angela Clerk 1 March 2014 - 28 February 2017	Click Add to select your project (received at Reading) from an autocomplete list.

Deposit Details

Date Deposited:	12 Jan 2021 23:40	Date item deposited into CentAUR
Last Modified:	28 Jul 2023 07:38	Date item last modified